Figure 3 | Scientific Reports

Figure 3

From: Modifications of liver stiffness and CXCL4, TGF-β1 and HGF are similar in HCV- and HIV/HCV-infected patients after DAAs

Figure 3

Changes in liver stiffness (A), serum chemokine (C-X-C motif) ligand 4 (CXCL4) (B), transforming growth factor β1 (TGF-β1) (C), and hepatocyte growth factor (HGF) (D) concentrations in HCV-infected patients without (HCV + HIV−) (n = 20) or with (HCV + HIV +) (n = 66) HIV coinfection, from inclusion to 12 months after that. Patients started with direct HCV antiviral agents at inclusion and achieved sustained viral HCV response. Data are shown as median, interquartile range and range.

Back to article page